Immunotherapie and Immunology news
A 2026 Phase I trial shows umbilical cord stem cells delivered directly to the liver can reverse cirrhosis markers.
Read More »A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Read More »How Much Does Stem Cell Therapy Cost in Thailand? Stem cell therapy in Thailand costs $3,500–$40,000 USD, depending on the treatment type, number of cells used, and protocol complexity. This is 50–70% less than equivalent treatments in the United States, Europe, or Australia — without compromising on quality or safety standards. Cost Breakdown by Treatment […]
Read More »Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
Read More »Your gut bacteria directly control how well your stem cells work. Here’s what every patient should know before treatment.
Read More »A technical review of 3D bioprinting for cartilage repair: thiolated bioinks, scaffold optimization, MSC chondrogenesis, and the path to clinical translation.
Read More »Learn how MSC therapy is offering real hope for liver cirrhosis patients — with data from the latest 2026 clinical trials and real patient outcomes at our Bangkok clinic.
Read More »Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.
Read More »A technical deep dive into MSC immunomodulation for autoimmune disease: Treg induction, macrophage polarization, and clinical evidence from the SMART-MS trial.
Read More »Discover how mesenchymal stem cell therapy is helping COPD, pulmonary fibrosis, and post-COVID lung damage patients breathe easier — right here in Bangkok, Thailand.
Read More »A New Chapter in Therapeutic Cell Engineering Mesenchymal stem cells — or more precisely, mesenchymal stromal cells — have occupied a unique niche in translational medicine for the better part of two decades. Their capacity for multilineage differentiation, coupled with robust immunomodulatory and trophic properties, has propelled them into hundreds of clinical trials spanning graft-versus-host […]
Read More »